Top Qs
Timeline
Chat
Perspective
MiPT
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
N-Methyl-N-isopropyltryptamine (MiPT) is a psychedelic tryptamine, closely related to DMT, DiPT and miprocin. It was first described by David Repke and colleagues in 1981[1][2][3][4] and was subsequently evaluated and described in Alexander Shulgin's 1997 book TiHKAL (Tryptamines I Have Known and Loved).[5]
Remove ads
Use and effects
Moderate effects have been reported at 10 to 25 mg ingested orally, with effects lasting 4 to 8 hours. One of the test subjects in TiHKAL reported moderate effects at 20 mg ingested intranasally.[6]
In TiHKAL,[5] the subjective experience is reported to be biased towards mental (psychedelic/entheogenic) effects, with mild perceptual (sensory/hallucinogenic) alterations relative to other tryptamines.[6] Subjects reported enhancement of the visual field (brightened and modulated color perception) but a lack of visual distortion typical of tryptamines such as psilocin. Enhancement of auditory perception was also noted. Documented physical effects include stimulation, dry mouth, and muscle tension.
Remove ads
Interactions
Chemistry
MiPT is the N-isopropyl analogue of DMT and the N-methyl analogue of DiPT.
MiPT base, unlike many other tryptamines in their freebase form, does not decompose rapidly in the presence of light or oxygen.[citation needed]
In August 2019, Chadeayne et al. solved the crystal structure of fumarate salt of MiPT.[7]
History
MiPT was first synthesized and described by David Repke and colleagues in 1981.[1][2][3][4]
Society and culture
Legal status
Sweden
Sweden's public health agency suggested classifying MiPT as a hazardous substance, on May 15, 2019.[8]
United States
In the United States, MiPT is unscheduled but purchase, sale, or possession for human consumption could be prosecuted under the Federal Analogue Act.[9]
See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads